Cargando…
Apolipoprotein A-I Supports MSCs Survival under Stress Conditions
Clinical trials have shown the safety of mesenchymal stem/stromal cells (MSCs) transplantation, but the effectiveness of these treatments is limited. Since, transplanted MSCs will undergo metabolic disturbances in the bloodstream, we investigated the influence of blood plasmas of type 2 diabetes (T2...
Autores principales: | Miroshnichenko, Svetlana, Usynin, Ivan, Dudarev, Alexey, Nimaev, Vadim, Solovieva, Anastasiya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312015/ https://www.ncbi.nlm.nih.gov/pubmed/32517119 http://dx.doi.org/10.3390/ijms21114062 |
Ejemplares similares
-
PRP of T2DM Patient Immobilized on PCL Nanofibers Stimulate Endothelial Cells Proliferation
por: Solovieva, Anastasiya O., et al.
Publicado: (2023) -
XPS Modeling of Immobilized Recombinant Angiogenin and Apoliprotein A1 on Biodegradable Nanofibers
por: Manakhov, Anton, et al.
Publicado: (2020) -
The Apolipoprotein B/Apolipoprotein A-I Ratio as a Potential Marker of Plasma Atherogenicity
por: Kaneva, Anastasiya M., et al.
Publicado: (2015) -
MSCs: Scientific Support for Multiple Therapies
por: Pittenger, Mark F., et al.
Publicado: (2015) -
iPSC-Derived MSCs Are a Distinct Entity of MSCs with Higher Therapeutic Potential than Their Donor-Matched Parental MSCs
por: Lee, Hae-Ri, et al.
Publicado: (2023)